Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90

被引:49
作者
Liu, Ping [1 ]
Xiao, Ji [1 ]
Wang, Yiliang [1 ]
Song, Xiaowei [1 ]
Huang, Lianzhou [1 ,2 ]
Ren, Zhe [1 ]
Kitazato, Kaio [3 ]
Wang, Yifei [1 ]
机构
[1] Jinan Univ, Coll Life Sci & Technol, Guangzhou Jinan Biomed Res & Dev Ctr, Guangzhou, Peoples R China
[2] Jinan Univ, Coll Pharm, Guangzhou, Peoples R China
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Res Pharm, Nagasaki, Japan
基金
中国国家自然科学基金;
关键词
HDAC6; Hsp90; Client proteins; Acetylation; Drug development; UBIQUITIN-PROTEASOME SYSTEM; TARGETING PROSTATE-CANCER; ANDROGEN RECEPTOR; GLUCOCORTICOID-RECEPTOR; CHAPERONE FUNCTION; TRANSCRIPTIONAL ACTIVITY; HDAC6; INHIBITION; DOWN-REGULATION; HSP90; STRESS;
D O I
10.1186/s10020-021-00375-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Posttranslational modification (PTM) and regulation of protein stability are crucial to various biological processes. Histone deacetylase 6 (HDAC6), a unique histone deacetylase with two functional catalytic domains (DD1 and DD2) and a ZnF-UBP domain (ubiquitin binding domain, BUZ), regulates a number of biological processes, including gene expression, cell motility, immune response, and the degradation of misfolded proteins. In addition to the deacetylation of histones, other nonhistone proteins have been identified as substrates for HDAC6. Hsp90, a molecular chaperone that is a critical modulator of cell signaling, is one of the lysine deacetylase substrates of HDAC6. Intriguingly, as one of the best-characterized regulators of Hsp90 acetylation, HDAC6 is the client protein of Hsp90. In addition to regulating Hsp90 at the post-translational modification level, HDAC6 also regulates Hsp90 at the gene transcription level. HDAC6 mainly regulates the Hsp90-HSF1 complex through the ZnF-UBP domain, thereby promoting the HSF1 entry into the nucleus and activating gene transcription. The mutual interaction between HDAC6 and Hsp90 plays an important role in the regulation of protein stability, cell migration, apoptosis and other functions. Plenty of of studies have indicated that blocking HDAC6/Hsp90 has a vital regulatory role in multifarious diseases, mainly in cancers. Therefore, developing inhibitors or drugs against HDAC6/Hsp90 becomes a promising development direction. Herein, we review the current knowledge on molecular regulatory mechanisms based on the interaction of HDAC6 and Hsp90 and inhibition of HDAC6 and/or Hsp90 in oncogenesis and progression, antiviral and immune-related diseases and other vital biological processes.
引用
收藏
页数:12
相关论文
共 99 条
[1]   HDAC6 Regulates Androgen Receptor Hypersensitivity and Nuclear Localization via Modulating Hsp90 Acetylation in Castration-Resistant Prostate Cancer [J].
Ai, Junkui ;
Wang, Yujuan ;
Dar, Javid A. ;
Liu, June ;
Liu, Lingqi ;
Nelson, Joel B. ;
Wang, Zhou .
MOLECULAR ENDOCRINOLOGY, 2009, 23 (12) :1963-1972
[2]   Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases [J].
Alam, Qamre ;
Alam, Mohammad Zubair ;
Sait, Khalid Hussain Wali ;
Anfinan, Nisreen ;
Noorwali, Abdul Wahab ;
Kamal, Mohammad Amjad ;
Khan, Mohd Sajjad Ahmad ;
Haque, Absarul .
CURRENT DRUG METABOLISM, 2017, 18 (09) :868-876
[3]   Developing potent PROTACs tools for selective degradation of HDAC6 protein [J].
An, Zixuan ;
Lv, Wenxing ;
Su, Shang ;
Wu, Wei ;
Rao, Yu .
PROTEIN & CELL, 2019, 10 (08) :606-609
[4]   Histone deacetylases in cardiovascular and metabolic diseases [J].
Bagchi, Rushita A. ;
Weeks, Kate L. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 130 :151-159
[5]   Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors [J].
Bali, P ;
Pranpat, M ;
Bradner, J ;
Balasis, M ;
Fiskus, W ;
Guo, F ;
Rocha, K ;
Kumaraswamy, S ;
Boyapalle, S ;
Atadja, P ;
Seto, E ;
Bhalla, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) :26729-26734
[6]   Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases [J].
Banerjee, Monimoy ;
Hatial, Ishita ;
Keegan, Bradley M. ;
Blagg, Brian S. J. .
PHARMACOLOGY & THERAPEUTICS, 2021, 221
[7]   4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]pyridines as a new class of cytotoxic Hsp90 inhibitors [J].
Baruchello, Riccardo ;
Simoni, Daniele ;
Marchetti, Paolo ;
Rondanin, Riccardo ;
Mangiola, Stefania ;
Costantini, Cristiana ;
Meli, Maria ;
Giannini, Giuseppe ;
Vesci, Loredana ;
Carollo, Valeria ;
Brunetti, Tiziana ;
Battistuzzi, Gianfranco ;
Tolomeo, Manlio ;
Cabri, Walter .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 76 :53-60
[8]   Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function [J].
Basak, Shashwati ;
Pookot, Deepa ;
Noonan, Emily J. ;
Dahiya, Rajvir .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) :3195-3202
[9]   Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease [J].
Benoy, Veronick ;
Vanden Berghe, Pieter ;
Jarpe, Matthew ;
Van Damme, Philip ;
Robberecht, Wim ;
Van den Bosch, Ludo .
NEUROTHERAPEUTICS, 2017, 14 (02) :417-428
[10]   HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates [J].
Boyault, Cyril ;
Zhang, Yu ;
Fritah, Sabrina ;
Caron, Cecile ;
Gilquin, Benoit ;
Kwon, So Hee ;
Garrido, Carmen ;
Yao, Tso-Pang ;
Vourc'h, Claire ;
Matthias, Patrick ;
Khochbin, Saadi .
GENES & DEVELOPMENT, 2007, 21 (17) :2172-2181